There's a Telegram group where Coconut aggressively promoted a stock trading at RM0.13. Despite the price dropping to RM0.10, they continued to hype its potential. Someone's lighthearted comment about the recommendation was met with a stern rebuke. I believe many people are holding onto this stock due to Coconut's misleading advice. Hopefully, the company can overcome its PN17 status and see its share price recover.
The last transaction pn17 restructuring plan is in March 2025, if company can not submit on time, generally on the bursa will give three months to half a year extension period, such as kmn are pn17 four years.pharma 2years already。
In this case can be renew the PN17....go ahead and buy the bright future outlook good is ahead.it is cheap surely make high profit.like kesang turn to Dbhd suspended later open up shoot up to RM 3.00
Buy gloves 🧤 stocks to protect your capital is coming and deadly type of Mpox already landed in Thailand 🇹🇭 just next to our bed ‼️buy cheap gloves counter such as Hexcare etc before to late ⏰✅
Put it Simple. Mother need to be at least 0.1 for son to move. So buy mother now. Mother now only 0.065. Worth to collect. Slowly but surely will above.
This Mustakim cant hope lah, From rm2 to 30 sen then 10 sen now 5.5 sen. See how hard Tony tries to do to save his Airasia. This Mustakim knows sell shares and cabut only. Think clearly before invest lah.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
SCM2023
95 posts
Posted by SCM2023 > 2 months ago | Report Abuse
There's a Telegram group where Coconut aggressively promoted a stock trading at RM0.13. Despite the price dropping to RM0.10, they continued to hype its potential. Someone's lighthearted comment about the recommendation was met with a stern rebuke. I believe many people are holding onto this stock due to Coconut's misleading advice. Hopefully, the company can overcome its PN17 status and see its share price recover.